Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Immune intervention in type 1 diabetes.

Michels AW, Eisenbarth GS.

Semin Immunol. 2011 Jun;23(3):214-9. doi: 10.1016/j.smim.2011.07.003. Epub 2011 Aug 17. Review.

PMID:
21852151
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Immunotherapy of type 1 diabetes: where are we and where should we be going?

Luo X, Herold KC, Miller SD.

Immunity. 2010 Apr 23;32(4):488-99. doi: 10.1016/j.immuni.2010.04.002. Review.

PMID:
20412759
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.

Fändrich F, Ungefroren H.

Adv Exp Med Biol. 2010;654:641-65. doi: 10.1007/978-90-481-3271-3_28. Review.

PMID:
20217518
[PubMed - indexed for MEDLINE]
4.

Gene therapy in type 1 diabetes.

Bagley J, Paez-Cortez J, Tian C, Iacomini J.

Crit Rev Immunol. 2008;28(4):301-24. Review.

PMID:
19166382
[PubMed - indexed for MEDLINE]
5.

Proinsulin-a pathogenic autoantigen in type 1 diabetes.

Narendran P, Mannering SI, Harrison LC.

Autoimmun Rev. 2003 Jun;2(4):204-10. Review.

PMID:
12848947
[PubMed - indexed for MEDLINE]
6.

Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Chen W, Xie A, Chan L.

Transl Res. 2013 Apr;161(4):217-29. doi: 10.1016/j.trsl.2012.12.017. Epub 2013 Jan 22. Review.

PMID:
23348026
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.

Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ.

Diabetes. 2007 Aug;56(8):2116-23. Epub 2007 May 11.

PMID:
17496235
[PubMed - indexed for MEDLINE]
Free Article
8.

Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.

Li CR, Baaten BJ, Bradley LM.

J Mol Cell Biol. 2012 Feb;4(1):38-47. doi: 10.1093/jmcb/mjr040. Epub 2011 Nov 24. Review.

PMID:
22116888
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans.

Serreze DV, Chen YG.

Trends Immunol. 2005 Nov;26(11):603-7. Epub 2005 Sep 2. Review.

PMID:
16140038
[PubMed - indexed for MEDLINE]
10.

Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.

Wang B, Tisch R.

Immunol Res. 2008;42(1-3):246-58. doi: 10.1007/s12026-008-8090-5.

PMID:
19052699
[PubMed - indexed for MEDLINE]
11.

The potential role of dendritic cells in the therapy of Type 1 diabetes.

Lee CN, Lew AM, Wu L.

Immunotherapy. 2013 Jun;5(6):591-606. doi: 10.2217/imt.13.48. Review.

PMID:
23725283
[PubMed - indexed for MEDLINE]
12.

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.

Marin-Gallen S, Clemente-Casares X, Planas R, Pujol-Autonell I, Carrascal J, Carrillo J, Ampudia R, Verdaguer J, Pujol-Borrell R, Borràs FE, Vives-Pi M.

Clin Exp Immunol. 2010 May;160(2):207-14. doi: 10.1111/j.1365-2249.2009.04082.x. Epub 2009 Dec 17.

PMID:
20030670
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.

Pietropaolo M, Towns R, Eisenbarth GS.

Cold Spring Harb Perspect Med. 2012 Oct 1;2(10). pii: a012831. doi: 10.1101/cshperspect.a012831. Review.

PMID:
23028135
[PubMed - indexed for MEDLINE]
14.

Preventing type 1 diabetes mellitus: the promise of gene therapy.

Efrat S.

Am J Pharmacogenomics. 2002;2(2):129-34. Review.

PMID:
12083947
[PubMed - indexed for MEDLINE]
15.

Parameters influencing antigen-specific immunotherapy for type 1 diabetes.

Wang B, Tisch R.

Immunol Res. 2008;41(3):175-87. doi: 10.1007/s12026-008-8020-6.

PMID:
18543112
[PubMed - indexed for MEDLINE]
16.

Clinical potential of antigen-specific therapies in type 1 diabetes.

Coppieters KT, Sehested Hansen B, von Herrath MG.

Rev Diabet Stud. 2012 Winter;9(4):328-37. doi: 10.1900/RDS.2012.9.328. Epub 2012 Dec 28. Review.

PMID:
23804270
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Type 1 Diabetes TrialNet--an international collaborative clinical trials network.

Skyler JS, Greenbaum CJ, Lachin JM, Leschek E, Rafkin-Mervis L, Savage P, Spain L; Type 1 Diabetes TrialNet Study Group.

Ann N Y Acad Sci. 2008 Dec;1150:14-24. doi: 10.1196/annals.1447.054.

PMID:
19120262
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Immunotherapy of type 1 diabetes.

Li L, Yi Z, Tisch R, Wang B.

Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):227-36. doi: 10.1007/s00005-008-0025-2. Epub 2008 Jul 29. Review.

PMID:
18726144
[PubMed - indexed for MEDLINE]
19.

2011 Update: antigen-specific therapy in type 1 diabetes.

Michels AW, von Herrath M.

Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):235-40. doi: 10.1097/MED.0b013e32834803ae. Review.

PMID:
21844706
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Immunotherapy for the prevention and treatment of type 1 diabetes.

Goudy KS, Tisch R.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):307-26. Review.

PMID:
16318984
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk